SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells
Bladder cancer is a very heterogeneous disease and the molecular mechanisms of carcinogenesis and progression are insufficiently investigated. From the DNA sequencing analysis of matched non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) samples from eight patients,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825079/ https://www.ncbi.nlm.nih.gov/pubmed/33418944 http://dx.doi.org/10.3390/cells10010080 |
_version_ | 1783640225460781056 |
---|---|
author | Kotolloshi, Roland Hölzer, Martin Gajda, Mieczyslaw Grimm, Marc-Oliver Steinbach, Daniel |
author_facet | Kotolloshi, Roland Hölzer, Martin Gajda, Mieczyslaw Grimm, Marc-Oliver Steinbach, Daniel |
author_sort | Kotolloshi, Roland |
collection | PubMed |
description | Bladder cancer is a very heterogeneous disease and the molecular mechanisms of carcinogenesis and progression are insufficiently investigated. From the DNA sequencing analysis of matched non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) samples from eight patients, we identified the tumour-associated gene SLC35F2 to be mutated in the 5′ and 3′ untranslated region (UTR). One mutation in 3′UTR increased the luciferase activity reporter, suggesting its influence on the protein expression of SLC35F2. The mRNA level of SLC35F2 was increased in MIBC compared with NMIBC. Furthermore, in immunohistochemical staining, we observed a strong intensity of SLC35F2 in single tumour cells and in the border cells of solid tumour areas with an atypical accumulation around the nucleus, especially in the MIBC. This suggests that SLC35F2 might be highly expressed in aggressive and invasive tumour cells. Moreover, knockdown of SLC35F2 repressed the growth of bladder cancer cells in the monolayer and spheroid model and suppressed migration and invasion of bladder cancer cells. In conclusion, we suggest that SLC35F2 is involved in bladder cancer progression and might provide a new therapeutic approach, for example, by the anti-cancer drug YM155, a cargo of the SLC35F2 transporter. |
format | Online Article Text |
id | pubmed-7825079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78250792021-01-24 SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells Kotolloshi, Roland Hölzer, Martin Gajda, Mieczyslaw Grimm, Marc-Oliver Steinbach, Daniel Cells Article Bladder cancer is a very heterogeneous disease and the molecular mechanisms of carcinogenesis and progression are insufficiently investigated. From the DNA sequencing analysis of matched non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) samples from eight patients, we identified the tumour-associated gene SLC35F2 to be mutated in the 5′ and 3′ untranslated region (UTR). One mutation in 3′UTR increased the luciferase activity reporter, suggesting its influence on the protein expression of SLC35F2. The mRNA level of SLC35F2 was increased in MIBC compared with NMIBC. Furthermore, in immunohistochemical staining, we observed a strong intensity of SLC35F2 in single tumour cells and in the border cells of solid tumour areas with an atypical accumulation around the nucleus, especially in the MIBC. This suggests that SLC35F2 might be highly expressed in aggressive and invasive tumour cells. Moreover, knockdown of SLC35F2 repressed the growth of bladder cancer cells in the monolayer and spheroid model and suppressed migration and invasion of bladder cancer cells. In conclusion, we suggest that SLC35F2 is involved in bladder cancer progression and might provide a new therapeutic approach, for example, by the anti-cancer drug YM155, a cargo of the SLC35F2 transporter. MDPI 2021-01-06 /pmc/articles/PMC7825079/ /pubmed/33418944 http://dx.doi.org/10.3390/cells10010080 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kotolloshi, Roland Hölzer, Martin Gajda, Mieczyslaw Grimm, Marc-Oliver Steinbach, Daniel SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title_full | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title_fullStr | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title_full_unstemmed | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title_short | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells |
title_sort | slc35f2, a transporter sporadically mutated in the untranslated region, promotes growth, migration, and invasion of bladder cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825079/ https://www.ncbi.nlm.nih.gov/pubmed/33418944 http://dx.doi.org/10.3390/cells10010080 |
work_keys_str_mv | AT kotolloshiroland slc35f2atransportersporadicallymutatedintheuntranslatedregionpromotesgrowthmigrationandinvasionofbladdercancercells AT holzermartin slc35f2atransportersporadicallymutatedintheuntranslatedregionpromotesgrowthmigrationandinvasionofbladdercancercells AT gajdamieczyslaw slc35f2atransportersporadicallymutatedintheuntranslatedregionpromotesgrowthmigrationandinvasionofbladdercancercells AT grimmmarcoliver slc35f2atransportersporadicallymutatedintheuntranslatedregionpromotesgrowthmigrationandinvasionofbladdercancercells AT steinbachdaniel slc35f2atransportersporadicallymutatedintheuntranslatedregionpromotesgrowthmigrationandinvasionofbladdercancercells |